We are live on ! Find out more
SS

SBI Securities Portfolio holdings

AUM $4.4B
1-Year Est. Return 74.26%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+74.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.89B
AUM Growth
-$15.1M
Cap. Flow
-$69.6M
Cap. Flow %
-1.79%
Top 10 Hldgs %
43.27%
Holding
4,279
New
94
Increased
1,155
Reduced
1,883
Closed
250

Top Sells

Rank Stock Value
1
ATEX icon
Anterix
ATEX
+$37.7M
2
TSLA icon
Tesla
TSLA
+$24.7M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$15.6M
4
NVDA icon
NVIDIA
NVDA
+$9.57M
5
PLTR icon
Palantir
PLTR
+$7.17M

Sector Composition

Rank Sector Weight
1 Miscellaneous 42.42%
2 Technology 28.51%
3 Communication Services 7.22%
4 Consumer Discretionary 6.74%
5 Financials 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSPI icon
3251
CSP Inc
CSPI
$82.1M
$175 ﹤0.01%
14
GIC icon
3252
Global Industrial
GIC
$1.51B
$175 ﹤0.01%
6
CLPS icon
3253
CLPS Inc
CLPS
$32.2M
$174 ﹤0.01%
217
-3
-1% -$3
GTN icon
3254
Gray Television
GTN
$497M
$174 ﹤0.01%
36
-30
-45% -$147
CHRN
3255
ChronoScale Holdings
CHRN
$2.73B
$173 ﹤0.01%
20
AMBR
3256
Amber International Holding Ltd
AMBR
$99M
$173 ﹤0.01%
100
+21
+27% +$41
BFRI icon
3257
Biofrontera
BFRI
$23.6M
$171 ﹤0.01%
300
-1
-0.3% -$1
JACK icon
3258
Jack in the Box
JACK
$311M
$171 ﹤0.01%
9
-85
-90% -$1.54K
LRMR icon
3259
Larimar Therapeutics
LRMR
$417M
$171 ﹤0.01%
45
-37
-45% -$144
ABTS icon
3260
Abits Group
ABTS
$4.4M
$170 ﹤0.01%
33
SLN
3261
Silence Therapeutics
SLN
$834M
$170 ﹤0.01%
28
-1
-3% -$6
ETON icon
3262
Eton Pharmaceutcials
ETON
$1.71B
$169 ﹤0.01%
10
-118
-92% -$2.08K
APLM icon
3263
Apollomics
APLM
$77M
$168 ﹤0.01%
9
-10
-53% -$184
CNTX icon
3264
Context Therapeutics
CNTX
$35.3M
$168 ﹤0.01%
114
-3
-3% -$4
HNI icon
3265
HNI Corp
HNI
$3.55B
$168 ﹤0.01%
4
+1
+33% +$42
TNGX icon
3266
Tango Therapeutics
TNGX
$3.94B
$168 ﹤0.01%
19
-35
-65% -$302
JYNT icon
3267
The Joint Corp
JYNT
$119M
$166 ﹤0.01%
19
MOGU
3268
MOGU Inc
MOGU
$15.4M
$166 ﹤0.01%
78
ORGO icon
3269
Organogenesis Holdings
ORGO
$224M
$166 ﹤0.01%
32
+15
+88% +$73
PXLW icon
3270
Pixelworks
PXLW
$41.9M
$165 ﹤0.01%
26
-1
-4% -$8
SYRE icon
3271
Spyre Therapeutics
SYRE
$7.97B
$164 ﹤0.01%
5
-118
-96% -$3.08K
TARS icon
3272
Tarsus Pharmaceuticals
TARS
$3.15B
$164 ﹤0.01%
2
-51
-96% -$3.81K
UVSP icon
3273
Univest Financial
UVSP
$1.15B
$164 ﹤0.01%
5
XPER icon
3274
Xperi
XPER
$293M
$164 ﹤0.01%
28
-1
-3% -$6
CNK icon
3275
Cinemark Holdings
CNK
$4.17B
$163 ﹤0.01%
7
-380
-98% -$9.99K

Similar funds

SBI Securities's Q4 2025 Portfolio in Review

As of Q4 2025, SBI Securities held 4,279 positions worth $3.89B, down 0.39% from $3.9B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

SBI Securities's Q4 2025 filing shows 94 new, 1,155 increased, 1,883 reduced and 250 closed positions. Its largest new stake was Berkshire Hathaway Class B: 74,213 shares worth $37.3M. The largest sale was Anterix, an estimated $37.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 42% a quarter earlier, followed by Technology and Communication Services.

  • SBI Securities's largest Q4 2025 buy was Berkshire Hathaway Class B: 74,213 shares worth $37.3M.
  • SBI Securities added most to Celsius Holdings in Q4 2025, an estimated $5.86M increase.
  • SBI Securities's biggest Q4 2025 reduction was Tesla, cutting an estimated $24.7M.
  • SBI Securities fully exited Anterix in Q4 2025, selling an estimated $37.7M.
  • SBI Securities's ten largest holdings make up 43% of its $3.89B portfolio in Q4 2025.
  • SBI Securities opened 94 new positions and closed 250 in Q4 2025.
  • SBI Securities's portfolio value fell 0.39% quarter-over-quarter to $3.89B.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.